Sufferers of Wet Macular Degeneration Have Hope
FDA Approves New Therapy
ROCKVILLE, MD-A therapy which slows vision loss of people with "wet" age-related macular degeneration (AMD) has been approved by the Food and Drug Administration (FDA). AMD, a retinal disease that is the major cause of blindness in people over 60 years old, is caused by the growth of abnormal leaky blood vessels, which damage the macula. The macula is the eye area responsible for the central field of vision as opposed to peripheral vision. If not treated, people with AMD can become functionally blind within two years. Though the FDA approved therapy, marketed as Visudyne therapy, does not stop or cure AMD, it slows the degenerating process. The therapy is a two-step process. First, an injection of Visudyne is injected into the patient's arm. Second, a laser light is shined into the patient's eye for 90 seconds. The laser activates the drug affecting the blood vessels and slowing the leak of fluid.
Visudyne therapy will be manufactured by QLT PhotoTherapeutics Inc. and marketed by CIBA Vision Corporation, the eye care unit of Novartis AG.
APIC Salutes 2025 Trailblazers in Infection Prevention and Control
June 18th 2025From a lifelong mentor to a rising star, the Association for Professionals in Infection Control and Epidemiology (APIC) honored leaders across the career spectrum at its 2025 Annual Conference in Phoenix, recognizing individuals who enhance patient safety through research, leadership, and daily practice.
Building Infection Prevention Capacity in the Middle East: A 7-Year Certification Success Story
June 17th 2025Despite rapid development, the Middle East faces a critical shortage of certified infection preventionists. A 7-year regional initiative has significantly boosted infection control capacity, increasing the number of certified professionals and elevating patient safety standards across health care settings.
Streamlined IFU Access Boosts Infection Control and Staff Efficiency
June 17th 2025A hospital-wide quality improvement project has transformed how staff access critical manufacturer instructions for use (IFUs), improving infection prevention compliance and saving time through a standardized, user-friendly digital system supported by unit-based training and interdepartmental collaboration.
